Clinical Trials Directory

Trials / Completed

CompletedNCT05661604

A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness

Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness

Status
Completed
Phase
Study type
Observational
Enrollment
140 (actual)
Sponsor
Janssen Research & Development, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to describe the rate of occurrence of clinical diagnosis of acute respiratory infection (an infection that affects normal breathing) and different types of respiratory pathogens (harmful organisms) of new respiratory infections in a population at high risk for severe illness.

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionThis is an observational study to assess the incidence and key disease characteristics of symptomatic acute respiratory viral infections in a high-risk population at risk for poor outcomes. Duration of each participant will be up to 12 months.

Timeline

Start date
2023-01-19
Primary completion
2024-03-31
Completion
2024-03-31
First posted
2022-12-22
Last updated
2025-02-28

Locations

4 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT05661604. Inclusion in this directory is not an endorsement.

A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness (NCT05661604) · Clinical Trials Directory